Status:
COMPLETED
Transcranial Magnetic Stimulation (TMS) for Treatment of Auditory Hallucinations
Lead Sponsor:
The University of New South Wales
Collaborating Sponsors:
NSW Schizophrenia Fellowship
Rebecca Cooper Medical Research Foundation
Conditions:
Auditory Hallucinations
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
Transcranial magnetic stimulation (TMS) involves the use of magnetic fields to non-invasively stimulate the brain. Studies overseas have suggested this may be an effective and safe treatment for audit...
Eligibility Criteria
Inclusion
- Over 18, with DSM-IV diagnosis of Schizophrenia and auditory hallucinations of clear external origins, refractory to pharmacotherapy and occurring at least 5 times per day.
Exclusion
- Subjects with contraindications to TMS (e.g. epilepsy, pacemaker) or those with an unacceptably high risk (e.g. suicide risk) will be excluded from the study.
Key Trial Info
Start Date :
September 1 1999
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2008
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT00763841
Start Date
September 1 1999
End Date
September 1 2008
Last Update
January 20 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
School of Psychiatry
Sydney, New South Wales, Australia, 2031